- In Memoriam
- Foreword to the First Edition
- Preface to the Second Edition
- Preface to the First Edition
- Contributors
- IBiological Bases of Pediatric Psychopharmacology
- II Somatic Interventions
- III Assessment and Treatment
- 41 Psychopharmacology and Substance Use Disorders: A Pediatric Approach
- 42 Individuals with Intellectual Disability
- 43 Psychopharmacology in the Medically Ill Child or Adolescent
- 44 Psychopharmacology During Pregnancy: Infant Considerations
- 45 Psychopharmacological Treatment in Preschoolers
- 46 Insomnia in Children and Adolescents
- IV Epidemiological, Research, and Methodological Considerations
- 49 Pediatric Psychopharmacoepidemiology: Who Is Prescribing? And For Whom, How, and Why?
- 50 Clinical Trials Methodology and Designs
- 51 Regulatory Issues
- 52 Ethical Issues in Pediatric Psychopharmacology
- 53 Conflict of Interest
- 54 International Patterns of Pediatric Medication for Emotional and Behavioral Disorders
- Appendix: Psychopharmacology at a Glance
- Disclosures of Financial Interests
- Index
Individuals with Intellectual Disability
- Chapter:
- Individuals with Intellectual Disability
- Author(s):
Michael G. Aman
, Cristan A. Farmer
, Ronald L. Lindsay
, and L. Eugene Arnold
- DOI:
- 10.1093/med/9780195398212.003.0042
Chapter 42 reviews the latest information on drug therapy for psychiatric conditions in children and adolescents with intellectual disability (ID), and addresses special considerations in this clinical population that may impinge on the use of psychotropic medicines.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- In Memoriam
- Foreword to the First Edition
- Preface to the Second Edition
- Preface to the First Edition
- Contributors
- IBiological Bases of Pediatric Psychopharmacology
- II Somatic Interventions
- III Assessment and Treatment
- 41 Psychopharmacology and Substance Use Disorders: A Pediatric Approach
- 42 Individuals with Intellectual Disability
- 43 Psychopharmacology in the Medically Ill Child or Adolescent
- 44 Psychopharmacology During Pregnancy: Infant Considerations
- 45 Psychopharmacological Treatment in Preschoolers
- 46 Insomnia in Children and Adolescents
- IV Epidemiological, Research, and Methodological Considerations
- 49 Pediatric Psychopharmacoepidemiology: Who Is Prescribing? And For Whom, How, and Why?
- 50 Clinical Trials Methodology and Designs
- 51 Regulatory Issues
- 52 Ethical Issues in Pediatric Psychopharmacology
- 53 Conflict of Interest
- 54 International Patterns of Pediatric Medication for Emotional and Behavioral Disorders
- Appendix: Psychopharmacology at a Glance
- Disclosures of Financial Interests
- Index
